Tópicos de metodología de la investigación y estadística en ciencias médicas
Diabetes mellitus is a multi factorial disorder related to a dysregulated metabolism. a holistic technique emphasizing each of the person factors with regards to finish pathophysiology of the disease is vital to our information of this heterogeneous
"Big data is defined as the collection of large and complex datasets available in structured, semi structured, and unstructured form which are dif cult to process using traditional database management tools or data processing applications. Big Data i
CLINICAL PATHWAYDeskripsi lengkap
clinical pathwayFull description
panduan CI
Clinical ReasoningFull description
Deskripsi lengkap
Descripción: Neuroradiologia Clinica
clinical pathway anestesiFull description
Full description
Descrição completa
examinationFull description
Clinical pathway stroke infark
Descrição completa
CLINICAL TRIALS , IMPORTANCE , METHOD OF CLINICAL TRIALSDescripción completa
Descrição completa
clinical pathwayDeskripsi lengkap
A discussion of Practical Research 2 (Definition, Types, Importance Across Fields, Characteristics, Limitations, Weaknesses, Research Topic, Problem, Questions and Title and Parts of Chapter…Full description
Full description
Full description
chlinical pathwayFull description
Full description
Clinical research MCQ’s
1. Rationalism implies all except [a] It is the pursuit of knowledge through reasoning. [b] leads to formal truth, which may or may not be materially true. [c] provides hypothesis for testing. [d] does not need empirical proof for its conclusions. Answer –d
2. True meaning of Empiricism is [a] Verication Verication by e!perimentation e!perimentation and observation. [b] "ractice based on opinion rather than evidence. [c] #o role in the pursuit of knowledge. [d] $omplementary to rationalism. Answer –d
3. The null hypothesis [a] Is the opposite of the research hypothesis. [b] "rovides, when re%ected, susupport for the research research hypothesis. [c] Is a tool in the reasoning process. [d] All of the above. Answer &d
4. hich statement is true association of a factor !ith an outcome [a] It is not a proof of causation. [b] 'e(uires 'e(uires further analysis before considering the factor as the cause. [c] )uggests causality if the outcome fails to occur without the factor [d] All the above Answer &d
". hich statement a#out sur$ey is true [a] It is a non&interventional study. [b] It is called case&control if it is retrospective. retrospective. [c] If it is prospective, is also called a cohort study.
[d] All the above Answer –d % &ll is true a#out clinical trials of 'rugs except [a] *hey are interventional studies. [b] *hey are e!periments. [c] *hey can be prospective or retrospective. [d] *hey usually have either parallel&groups or cross&over design. Answer &c
(. Metho'ological lan'mar)s in clinical trials inclu'e [a] +se of placebo as a control. [b] 'andomiation to remove bias in assignment. [c] -asking of treatment identity to remove bias in assessment. [d] All the above Answer –d
*. &ll is true a#out +eclaration of ,elsin)i except [a] It is the current I$ standard of ethics in biomedical e!periments on human sub%ects. [b] It was revised latest in /000 at 1dinburgh. [c] It has an e!planatory note on the use of placebo as control, issued in /00/. [d] It was adopted by the 2-A in 3456. Answer &a
-. The ethics of human experimentation ha$e #een outline' #y except [a] *he 27 in 8eclaration of elsinki [b] India in the I$-' guidelines [c] *he $8)$7 in its 9$" guidelines [d] *he +) :8A in its 9$" guidelines Answer &a
1. /C0 or goo' clinical practice [a] Is applicable only to clinical trials of drugs and devices.
[b] Aims to protect the rights and safety of the research sub%ects. [c] 8oes not aim to prevent fraud and misconduct. [d] Is outlined in I$: document 1;. Answer –b
11 hich of the follo!ing !oul' you most often associate 0hase Trials !ith [a] uman "harmacology [b] *herapeutic +se [c] *herapeutic $onrmatory [d] *herapeutic 1!ploratory Answer –b
12 n !hich clinical phase !oul' you generally expect the trials to #e con'ucte' in a group of patients !ho are selecte' #y relati$ely narro! criteria lea'ing to a relati$ely homogeneous population !hich are closely monitore' 'uring the trial an' the trial is examining therapeutic e5cacy [a] "hase I [b] "hase II [c] "hase IIIa [d] "hase IIIb Answer –b
13 0hase clinical trial loo) at the pharmaco)inetics of a test pro'uct. hichof the follo!ing statements is not true a#out pharmaco)inetics [a] "harmacokinetics looks at whether the product demonstrates e
14 & recent 'e$elopment in Clinical Trial 0hases has #een the concept of 0hase Trials. hich of the follo!ing coul' potentially #e classi6e' as 0hase [a] "re&clinical animal testing [b] :irst&in&man to study the pharmacokinetics and drug target e=ects of a low subtherapeutic dose [c] :irst&in&man trials for medical devices [d] *rials using human tissue collected from patients but not conducted in the patient Answer –b
1" 0hase trials often loo) at &+ME of a pro'uct. The &+ME is sometimes exten'e' an' referre' to as 7&+ME. hat 'oes the 7 stan' for [a] >oading [b] >imiting [c] >iberation